CoChat

Metabolic syndrome in women with previous gestational diabetes

Open access

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

To evaluate the incidence and timing of the diagnosis of metabolic syndrome in a cohort of Danish women after a pregnancy with gestational diabetes (GDM) to estimate the optimum time for preventative actions in relation to metabolic syndrome (MetS). In this follow-up study, 435 women were included from a consecutive cohort with prior history of GDM. Data on dyslipidemia, hypertension and other cardiovascular disorders (CVD) were extracted from the electronic patient journal. Any antidiabetic, cardiovascular and cholesterol-lowering medicine was ascertained in the national prescription database. Similarly, any blood test taken was evaluated. We defined a patient having MetS if the criteria of the WHO based definition of diabetes or impaired glucose regulation were met. Further, we added as alternative for glucose intolerance, a glycosylated hemoglobin (HbA1c) > 44 mmol/mol or the former level ≥ 6.5%. Further, dyslipidemia, lipid lowering medications, BMI > 30 kg/m 2 or antihypertensive treatment were used. For MetS outcome, diagnosis or medication for CVD was registered. All women were followed for median 5.7 years (range 0; 9). The incidence of MetS was 28%. Thirteen percent of these qualified already within one year after pregnancy for the diagnosis of MetS. Postpartum MetS was detected after a median of 3 years (range 0; 7 years); further, 36 (8%) had been diagnosed with manifest diabetes after pregnancy. The diagnosis of postpartum MetS was strongly associated with the prevalence of manifest diabetes. Six years after pregnancy the rate of metabolic syndrome was more than tripled (25 vs. 89%, no DM vs manifest DM, RR: 6.7; 95% CI 2.7–17, p < 0.001). At 40 years the MetS rate nearly tripled if manifest DM was diagnosed (26 vs. 78%, no DM vs. manifest DM, RR: 3.3, 95% CI 1.8–6, p < 0.001). We found that GDM and later on manifest DM in women increase the risk of metabolic syndrome. There seems to be a window of opportunity before the early thirties where it would be especially beneficial to begin preventive efforts in women with GDM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-021-90832-0

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Diagnosis of metabolic syndrome after gestational diabetes in pregnancy by subsequent manifest diabetes. Full line: Women with subsequent diabetes; interrupted line: Women without manifest diabetes. No diabetes vs. manifest diabetes: p > 0.001.
Figure 1 Diagnosis of metabolic syndrome after gestational diabetes in pregnancy by subsequent manifest diabetes. Full line: Women with subsequent diabetes; interrupted line: Women without manifest diabetes. No diabetes vs. manifest diabetes: p > 0.001.CC BY · PubMed Central
Figure 2 Age at diagnosis of metabolic syndrome by subsequent manifest diabetes. Horizontal line indicating when 50% of women were diagnosed with MetS. Full line: Women with subsequent diabetes; interrupted line: Women without manifest diabetes. No diabetes vs. manifest diabetes: p > 0.001.
Figure 2 Age at diagnosis of metabolic syndrome by subsequent manifest diabetes. Horizontal line indicating when 50% of women were diagnosed with MetS. Full line: Women with subsequent diabetes; interrupted line: Women without manifest diabetes. No diabetes vs. manifest diabetes: p > 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 32

Metadata

Authors
Kaiser, K., Nielsen, M. F., Kallfa, E., Dubietyte, G., & Lauszus, F. F.
Affiliations
  • Sygehus Sønderjylland (DK)
  • Region of Southern Denmark (DK)
Corresponding author
Lauszus, Finn Friis
Venue
Scientific Reports
Published
2021-06-02
Volume
11
Issue
1
Pages
11558-11558
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3165040643
Cited by
30
References
21
Citations by year
2026: 2 · 2025: 8 · 2024: 5 · 2023: 7 · 2022: 7 · 2021: 1
FWCI
4.54
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
metabolic syndrome, gestational diabetes mellitus, type 2 diabetes, dyslipidemia, hypertension, cardiovascular disease, incidence, time to diagnosis, prevention, women
MeSH terms
Adult, Female, Follow-Up Studies, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Middle Aged, Pregnancy, Diabetes, Gestational, Metabolic Syndrome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic syndrome in women with previous gestational diabetes. https://app.cochat.ai/papers/10.1038/s41598-021-90832-0
The paper
Kaiser, K., Nielsen, M. F., Kallfa, E., Dubietyte, G., & Lauszus, F. F. (2021). Metabolic syndrome in women with previous gestational diabetes. Scientific Reports. https://doi.org/10.1038/s41598-021-90832-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.